News & Updates
Filter by Specialty:
Sarcoidosis patients on systemic corticosteroid at higher risk of death
The risk of death is increased among patients with sarcoidosis compared with the general population, suggests a recent study, noting that mortality is even higher in those treated with systemic corticosteroids.
Sarcoidosis patients on systemic corticosteroid at higher risk of death
02 Mar 2022
First data from Vaccine Allergy Safety clinics reaffirm COVID-19 vaccine safety
First data from Vaccine Allergy Safety (VAS) clinics in Hong Kong show that a majority of high-risk patients can receive coronavirus disease 2019 (COVID-19) vaccination safely, with no immediate allergic reactions.
First data from Vaccine Allergy Safety clinics reaffirm COVID-19 vaccine safety
01 Mar 2022
Early ivermectin does not prevent progression to severe COVID-19
The early addition of ivermectin to standard of care (SoC)* in high-risk patients with mild-to-moderate COVID-19 did not prevent progression to severe disease compared with SoC alone, according to results of the I-TECH** trial conducted in Malaysia.
Early ivermectin does not prevent progression to severe COVID-19
28 Feb 2022
Booster dose effective in reducing COVID-19 across ages in adults
The risk of COVID-19 is substantially reduced in adults who receive a third “booster” dose of the BNT162b2 vaccine regardless of their age, according to a study from Israel.
Booster dose effective in reducing COVID-19 across ages in adults
23 Feb 2022
Stroke risk elevated first 3 days post–COVID-19 diagnosis
Older patients with COVID-19 may have an increased risk of being hospitalized for acute ischaemic stroke (AIS), particularly in the first 3 days following their COVID-19 diagnosis, according to a study presented at ISC 2022.